Jean-Jacques Bienaime

Chief Executive Officer
BioMarin Pharmaceutical Inc.

Jean-Jacques Bienaime is chief executive officer of BioMarin, a fully integrated biopharmaceutical company with more than 1,300 employees that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Bienaime joined the company in May 2005 as chief executive officer and member of the board of directors, bringing with him more than 25 years of experience in the biotechnology and pharmaceutical industries.

From November 2002 to April 2005, Bienaime served as chairman, chief executive officer and president of Genencor, a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics. From 1998 to late 2002, he served as chairman, chief executive officer and president of sangstat medical corporation, an immunology-focused biotechnology company that he guided to profitability prior to its acquisition by Genzyme Corporation.

Bienaime currently serves on the boards of biotechnology companies Intermune, Inc. and Vital Therapies, Inc., as well as the Biotech Industry Organization (BIO).